XML 97 R57.htm IDEA: XBRL DOCUMENT v3.20.2
Supplemental Information (Narrative) (Details) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Supplemental Information [Abstract]      
Payables for purchased receivables $ 34   $ 32
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 38 months    
Effective Income Tax Rate Reconciliation, Share-based Compensation, Excess Tax Benefit, Amount $ 8 $ 14  
Deferred Compensation Liability, Classified, Noncurrent $ 87   $ 86
Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 294,320    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value $ 24    
Stock Issued During Period Percentage Conversion Of Units, Low End 0.00%    
Stock Issued During Period Percentage Conversion Of Units, High End 200.00%    
Performance Shares | Market performance measures achievement      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 252,370    
Performance Shares | Renewable generation and energy storage installation targets      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 41,950    
Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 132,307    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value $ 10